Trend in cervical cancer screening in Spain (2003-2009) and predictors of adherence
- PMID: 22129658
- DOI: 10.1097/CEJ.0b013e32834a7e46
Trend in cervical cancer screening in Spain (2003-2009) and predictors of adherence
Abstract
Cervical cancer remains a public health problem in developed countries. Early detection of both premalignant lesions and cervical cancer through an appropriate screening programme may decrease its incidence and mortality. High rates of participation are essential to ensure the desired impact on the population. The aims of this study were to assess the use of Pap smears in Spain in 2009 to identify factors associated with screening adherence (predictors) and assess the trend from 2003 to 2009. We included women surveyed in the European Health Interview Survey for Spain. Cervical cancer screening included self-reported Pap smears over the last 3 years. The target age range was 25-64 years. The following independent variables were analysed: sociodemographic variables, chronic conditions, and lifestyle. Predictors of Pap smear adherence were explored using multivariate logistic regression. The screening coverage in the target population was 66.1% (95% confidence interval: 64.8-67.4). Undergoing Pap smears was associated positively with the following: being married, higher levels of education and income, having visited a general practitioner in previous weeks, and suffering from musculoskeletal disease. Belonging to an older age group (55-64 years) and obesity were associated with nonadherence to Pap smears. We did not find significant differences when we compared cervical cancer screening adherence over time since 2003. Adherence to cervical cancer screening in Spain does not seem to be improving. An effort must be made, and the implementation of population-based programmes instead of opportunistic screening could be considered, to recruit women who are less likely to undergo screening.
Similar articles
-
Breast and cervical cancer screening in Spain and predictors of adherence.Eur J Cancer Prev. 2010 May;19(3):239-45. doi: 10.1097/CEJ.0b013e3283372125. Eur J Cancer Prev. 2010. PMID: 20110817
-
Adherence to breast and cervical cancer screening in Spanish women with diabetes: associated factors and trend between 2006 and 2010.Diabetes Metab. 2012 Apr;38(2):142-8. doi: 10.1016/j.diabet.2011.09.007. Epub 2011 Nov 9. Diabetes Metab. 2012. PMID: 22078638
-
Predictors of breast and cervical cancer screening in a Spanish metropolitan area.J Womens Health (Larchmt). 2010 Sep;19(9):1675-81. doi: 10.1089/jwh.2009.1828. J Womens Health (Larchmt). 2010. PMID: 20799924
-
Effective screening programmes for cervical cancer in low- and middle-income developing countries.Bull World Health Organ. 2001;79(10):954-62. Epub 2001 Nov 1. Bull World Health Organ. 2001. PMID: 11693978 Free PMC article. Review.
-
Screening for cervical cancer, a priority in Zimbabwe?Cent Afr J Med. 2000 Mar;46(3):81-6. doi: 10.4314/cajm.v46i3.8528. Cent Afr J Med. 2000. PMID: 14674218 Review.
Cited by
-
Five-Year Overall Survival of Interval Breast Cancers is Better than Non- Interval Cancers from Korean Breast Cancer Registry.Asian Pac J Cancer Prev. 2019 Jun 1;20(6):1717-1726. doi: 10.31557/APJCP.2019.20.6.1717. Asian Pac J Cancer Prev. 2019. PMID: 31244292 Free PMC article.
-
Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.PLoS One. 2018 Jun 21;13(6):e0198939. doi: 10.1371/journal.pone.0198939. eCollection 2018. PLoS One. 2018. PMID: 29927995 Free PMC article.
-
Defining and measuring adherence to cancer screening.J Med Screen. 2016 Dec;23(4):179-185. doi: 10.1177/0969141316630766. Epub 2016 Mar 4. J Med Screen. 2016. PMID: 26946420 Free PMC article.
-
The impact of predisposing, enabling, and need factors in utilization of health services among rural residents in Guangxi, China.BMC Health Serv Res. 2016 Oct 19;16(1):592. doi: 10.1186/s12913-016-1825-4. BMC Health Serv Res. 2016. PMID: 27760531 Free PMC article.
-
Trends and Racial/Ethnic Differences in Predictors of Cervical Cancer Screening among US Women Ages 30-64 Years.Cancer Epidemiol Biomarkers Prev. 2023 Jan 9;32(1):82-90. doi: 10.1158/1055-9965.EPI-22-0970. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 36306382 Free PMC article.